Phase 1 Acute Lymphoblastic Leukaemia Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Acute Lymphoblastic LeukaemiaAcute Myeloid Leukaemia
AstraZeneca84 enrolled30 locationsNCT07155226
Not Yet Recruiting
Phase 1
Safety of Immune Cells for Patients with Relapsed Leukaemia or Lymphoma after Chemotherapy
Acute Lymphoblastic LeukaemiaNon-Hodgkins LymphomaChronic Lymphocytic Leukaemia
Western Sydney Local Health District, Westmead Hospital20 enrolled11 locationsACTRN12619000079145
Recruiting
Phase 1
Safety of Immune Cells for Patients with Relapsed Leukaemia or Lymphoma after Bone Marrow Transplant
Acute Lymphoblastic LeukaemiaNon-Hodgkins LymphomaChronic Lymphocytic Leukaemia
Western Sydney Local Health District, Westmead Hospital20 enrolled3 locationsACTRN12617001579381